FDA explains approval status of Pfizer vaccine

National and World

Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. (REUTERS/Andrew Kelly)

(WEHT) – The FDA says they want to clear up some misconceptions about their approval of the Pfizer-BioNTech’s COVID-19 vaccine.

The FDA explained that the vaccine is fully approved for patients above the age of 16. It is still authorized for emergency use for patients aged 12 to 15. The third dose for immunocompromised people is also authorized for emergency use.

For more information, click here.

Copyright 2021 Nexstar Media Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Trending Stories